Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₺55.60 |
52 Week High | ₺69.20 |
52 Week Low | ₺26.44 |
Beta | 0.14 |
1 Month Change | 3.73% |
3 Month Change | -7.79% |
1 Year Change | 76.51% |
3 Year Change | 270.42% |
5 Year Change | 1,722.95% |
Change since IPO | 1,916.54% |
Recent News & Updates
Recent updates
Shareholder Returns
SELEC | TR Healthcare | TR Market | |
---|---|---|---|
7D | 4.5% | 0.6% | -1.4% |
1Y | 76.5% | 80.6% | 73.8% |
Return vs Industry: SELEC underperformed the TR Healthcare industry which returned 80.6% over the past year.
Return vs Market: SELEC exceeded the TR Market which returned 73.8% over the past year.
Price Volatility
SELEC volatility | |
---|---|
SELEC Average Weekly Movement | 8.0% |
Healthcare Industry Average Movement | 8.1% |
Market Average Movement | 8.7% |
10% most volatile stocks in TR Market | 12.5% |
10% least volatile stocks in TR Market | 6.3% |
Stable Share Price: SELEC is not significantly more volatile than the rest of TR stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: SELEC's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1958 | 5,943 | n/a | https://www.selcukecza.com.tr |
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. operates as a pharmacy depot and organizes distribution channels between drug manufacturers, hospitals, and pharmacies. It also operates pharmaceutical warehouses. In addition, the company distributes cosmetics, personal care, infant food, vitamins, medical, and other products.
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Fundamentals Summary
SELEC fundamental statistics | |
---|---|
Market Cap | ₺34.53b |
Earnings (TTM) | ₺3.25b |
Revenue (TTM) | ₺69.75b |
10.6x
P/E Ratio0.5x
P/S RatioIs SELEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SELEC income statement (TTM) | |
---|---|
Revenue | ₺69.75b |
Cost of Revenue | ₺62.72b |
Gross Profit | ₺7.03b |
Other Expenses | ₺3.78b |
Earnings | ₺3.25b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 5.24 |
Gross Margin | 10.08% |
Net Profit Margin | 4.66% |
Debt/Equity Ratio | 25.8% |
How did SELEC perform over the long term?
See historical performance and comparison